143 related articles for article (PubMed ID: 35392867)
61. Identification and validation of smoking-related genes in lung adenocarcinoma using an in vitro carcinogenesis model and bioinformatics analysis.
Wang J; Chen T; Yu X; OUYang N; Tan L; Jia B; Tong J; Li J
J Transl Med; 2020 Aug; 18(1):313. PubMed ID: 32795291
[TBL] [Abstract][Full Text] [Related]
62. Aberrant Methylation and Differential Expression of SLC2A1, TNS4, GAPDH, ATP8A2, and CASZ1 Are Associated with the Prognosis of Lung Adenocarcinoma.
Wang X; Shi D; Zhao D; Hu D
Biomed Res Int; 2020; 2020():1807089. PubMed ID: 33029490
[TBL] [Abstract][Full Text] [Related]
63. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
64. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
65. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma.
Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C
Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347
[TBL] [Abstract][Full Text] [Related]
66. Multiomics analysis on DNA methylation and the expression of both messenger RNA and microRNA in lung adenocarcinoma.
Yang Z; Liu B; Lin T; Zhang Y; Zhang L; Wang M
J Cell Physiol; 2019 May; 234(5):7579-7586. PubMed ID: 30370535
[TBL] [Abstract][Full Text] [Related]
67. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
[TBL] [Abstract][Full Text] [Related]
68. DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients.
Wu ZH; Tang Y; Zhou Y
Cancer Control; 2021; 28():1073274820988519. PubMed ID: 33504182
[TBL] [Abstract][Full Text] [Related]
69. Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis.
Jiang X; Gao Y; Zhang N; Yuan C; Luo Y; Sun W; Zhang J; Ren J; Gong Y; Xie C
Cell Transplant; 2020; 29():963689720977131. PubMed ID: 33334139
[TBL] [Abstract][Full Text] [Related]
70. Role of endothelin receptor type B (EDNRB) in lung adenocarcinoma.
Wei F; Ge Y; Li W; Wang X; Chen B
Thorac Cancer; 2020 Jul; 11(7):1885-1890. PubMed ID: 32394530
[TBL] [Abstract][Full Text] [Related]
71. Immune landscape and a promising immune prognostic model associated with TP53 in early-stage lung adenocarcinoma.
Wu C; Rao X; Lin W
Cancer Med; 2021 Feb; 10(3):806-823. PubMed ID: 33314730
[TBL] [Abstract][Full Text] [Related]
72. Identification of four methylation-driven genes as candidate biomarkers for monitoring single-walled carbon nanotube-induced malignant transformation of the lung.
Xie D; Luo X
Toxicol Appl Pharmacol; 2021 Feb; 412():115391. PubMed ID: 33387576
[TBL] [Abstract][Full Text] [Related]
73. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
Zhang QH; Dai XH; Dai ZM; Cai YN
Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
[TBL] [Abstract][Full Text] [Related]
74. Prognostic Hub Genes in the Immune Microenvironment of Lung Adenocarcinoma by Estimation.
Liu S; Tian W; Li B
Comb Chem High Throughput Screen; 2022; 25(1):77-89. PubMed ID: 33308118
[TBL] [Abstract][Full Text] [Related]
75. A Novel Role of Arrhythmia-Related Gene
Chang KT; Wu HJ; Liu CW; Li CY; Lin HY
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216393
[TBL] [Abstract][Full Text] [Related]
76. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
Zhong M; Jiang Q; Jin R
IUBMB Life; 2018 Jul; 70(7):670-677. PubMed ID: 29667299
[TBL] [Abstract][Full Text] [Related]
77. Profiles of immune infiltration in lung adenocarcinoma and their clinical significant: A gene-expression-based retrospective study.
Chen G; Dong Z; Wu D; Chen Y
J Cell Biochem; 2020 Nov; 121(11):4431-4439. PubMed ID: 32003059
[TBL] [Abstract][Full Text] [Related]
78. Identification of a four-gene panel predicting overall survival for lung adenocarcinoma.
Li C; Long Q; Zhang D; Li J; Zhang X
BMC Cancer; 2020 Dec; 20(1):1198. PubMed ID: 33287749
[TBL] [Abstract][Full Text] [Related]
79. [Expression and prognosis effect of methylation-regulated SLIT3 and SPARCL1 genes in smoking-related lung adenocarcinoma].
Wang J; Yu XF; Ouyang N; Zhao SY; Guan XF; Yao HP; Chen R; Chen T; Li JX
Zhonghua Yi Xue Za Zhi; 2019 May; 99(20):1553-1557. PubMed ID: 31154721
[No Abstract] [Full Text] [Related]
80. Genetic analyses of differences between solid and nonsolid predominant lung adenocarcinomas.
Luo J; Ma K; Shi Y; Chen Z; Zhao M; Huang Y; Wang S; Xi J; Zhan C; Xu S; Wang Q
Thorac Cancer; 2018 Dec; 9(12):1656-1663. PubMed ID: 30276966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
